Sfoglia per AUTORE
ANNOVAZZI P
Collezione AOU San Luigi di Orbassano

  

Items : 22

Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Feb;70:104474. doi: 10.1016/j.msard.2022.104474. Epub 2022 Dec 19.
2023
AOU San Luigi di Orbassano

Patti F; Chisari CG; Toscano S; Annovazzi P; Banfi P; Bergamaschi R; Clerici R; Conti MZ; Cortese A; Fantozzi R; Ferraro D; Fischetti M; Frigo M; Gatto M; Immovilli P; Leoni S; Malucchi S; Maniscalco G; Marfia GA; Paolicelli D; Perini P; Serrati C; Totaro R; Turano G; Valentino P; Zaffaroni M; Zuliani C; Centonze D; Patti F; et alii...

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

A real-world study of alemtuzumab in a cohort of Italian patients. in European journal of neurology / Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5.
2022
AOU San Luigi di Orbassano

Russo CV; Saccà F; Frau J; Annovazzi P; Signoriello E; Bonavita S; Grasso R; Clerico M; Cordioli C; Laroni A; Capobianco M; Torri Clerici V; Sartori A; Cavalla P; Maniscalco GT; La Gioia S; Caleri F; Giugno A; Iodice R; Carotenuto A; Cocco E; Fenu G; Zaffaroni M; Baroncini D; Lus G; Gallo A; De Mercanti SF; Lapucci C; Di Francescantonio V; et alii...

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Cocco E; Gasperini C; Solaro C; Gazzola P; Gallo A; Maniscalco GT; Paolicelli D; Calabrese M; Borrelli A; Tomassini V; De Luca G; Clerico M; Boffa L; Lanzillo R; Moccia M; Ferraro D; Gajofatto A; Prosperini L; Fantozzi R; Buttari F; Laroni A; Lorefice L; Radaelli M; Nociti V; Torri Clerici V; Cavalla P; Annovazzi P; Malucchi S; et alii...

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study. in Journal of neurology / J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano

Bucello S; Annovazzi P; Ragonese P; Altieri M; Barcella V; Bergamaschi R; Bianchi A; Borriello G; Buscarinu MC; Callari G; Capobianco M; Capone F; Cavalla P; Cavarretta R; Cortese A; De Luca G; Di Filippo M; Dattola V; Fantozzi R; Ferraro E; Filippi MM; Gasperini C; Grimaldi LME; Landi D; Re ML; Mallucci G; Manganotti P; Marfia GA; Mirabella M; et alii...

Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Oct;45:102394. doi: 10.1016/j.msard.2020.102394. Epub 2020 Jul 12.
2020
AOU San Luigi di Orbassano

Moccia M; Annovazzi P; Buscarinu MC; Calabrese M; Cavalla P; Cordioli C; Di Filippo M; Ferraro D; Gajofatto A; Gallo A; Lanzillo R; Laroni A; Lorefice L; Mallucchi S; Nociti V; Paolicelli D; Pinardi F; Prosperini L; Radaelli M; Ragonese P; Tomassini V; Tortorella C; Cocco E; Gasperini C; Solaro C;

Cladribine vs other drugs in MS: Merging randomized trial with real-life data. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2020 Aug 14;7(6):e878. doi: 10.1212/NXI.0000000000000878. Print 20
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sormani MP; Visconti A; Landi D; Ippolito D; Esposito S; Russo CV; Barrilà C; Barone S; Grasso R; Pontecorvo S; Di Sapio A; Stromillo ML; Cordioli C; Rasia S; Sartori A; Clerici VT; Fenu G; Cocco E; Frau J; Barcella V; Frigeni B; La Gioia S; Pareja-Gutierrez L; Laroni A; Zarbo IR; Lavorgna L; Bonavita S; Perini P; Mataluni G; et alii...

First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102059. doi: 10.1016/j.msard.2020.102059. Epub 2020 Mar 16.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Signori A; Sormani MP; Carmisciano L; Turano G; Ippolito D; Russo CV; Frigeni B; Landi D; Barrilà C; Barone S; Lavorgna L; Grasso R; Di Sapio A; Cerqua R; Pontecorvo S; Stromillo ML; Cordioli C; Signoriello E; Rasia S; Sartori A; Zarbo IR; Laroni A; Frau J; Cocco E; Torri Clerici V; La Gioia S; Gutierrez LP; Clerico M; Mataluni G; et alii...

Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102124. doi: 10.1016/j.msard.2020.102124. Epub 2020 Apr 13.
2020
AOU San Luigi di Orbassano

Patti F; Chisari CG; D'Amico E; Annovazzi P; Banfi P; Bergamaschi R; Clerici R; Conti MZ; Cortese A; Fantozzi R; Fischetti M; Frigo M; Gatto M; Immovilli P; Leoni S; Malucchi S; Maniscalco G; Marfia GA; Paolicelli D; Perini P; Serrati C; Sola P; Totaro R; Turano G; Valentino P; Zaffaroni M; Zuliani C; Centonze D;

Informing MS patients on treatment options: a consensus on the process of consent taking. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Aug;41(8):2249-2253. doi: 10.1007/s10072-020-04339-z. Epub 2020 Apr 2.
2020
AOU San Luigi di Orbassano

Tortorella C; Solaro C; Annovazzi P; Boffa L; Buscarinu MC; Buttari F; Calabrese M; Cavalla P; Cocco E; Cordioli C; De Luca G; Di Filippo M; Fantozzi R; Ferraro D; Gajofatto A; Gallo A; Lanzillo R; Laroni A; Fermo SL; Malucchi S; Maniscalco GT; Moccia M; Nociti V; Paolicelli D; Pesci I; Prosperini L; Ragonese P; Tomassini V; Clerici VLAT; et alii...

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study. in Journal of neurology / J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17.
2019
AOU San Luigi di Orbassano

Frau J; Saccà F; Signori A; Baroncini D; Fenu G; Annovazzi P; Capobianco M; Signoriello E; Laroni A; La Gioia S; Sartori A; Maniscalco GT; Bonavita S; Clerico M; Russo CV; Gallo A; Lapucci C; Carotenuto A; Sormani MP; Cocco E;

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4.
2019
AOU San Luigi di Orbassano

Novi G; Bovis F; Capobianco M; Frau J; Mataluni G; Curti E; Zuliani L; Cavalla P; Brambilla L; Annovazzi P; Repice AM; Lanzillo R; Esposito S; Benedetti L; Maietta I; Sica F; Buttari F; Malucchi S; Fenu G; Landi D; Bosa C; Realmuto S; Malentacchi M; Granella F; Signori A; Bonavita S; Uccelli A; Sormani MP;

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study. in Neurology / Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.
2019
AOU San Luigi di Orbassano

Calabrese M; Gasperini C; Tortorella C; Schiavi G; Frisullo G; Ragonese P; Fantozzi R; Prosperini L; Annovazzi P; Cordioli C; Di Filippo M; Ferraro D; Gajofatto A; Malucchi S; Lo Fermo S; De Luca G; Stromillo ML; Cocco E; Gallo A; Paolicelli D; Lanzillo R; Tomassini V; Pesci I; Rodegher ME; Solaro C;

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. in Journal of neurology / J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.
2018
ASL Vercelli
AOU San Luigi di Orbassano

Gajofatto A; Pesci I; Laroni A; Coghe G; Gallo A; Pinardi F; Buscarinu MC; Di Filippo M; Maniscalco GT; Ragonese P; Buttari F; Boffa L; Clerici VT; Malucchi S; Radaelli M; Cavalla P; Annovazzi P; Nociti V; Tortorella C; Fantozzi R; Moccia M; Gasperini C; Prosperini L; Lanzillo R; Calabrese M; Tomassini V; Cocco E; Solaro C;

Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2018 Dec;7(2):391-393. doi: 10.1007/s40120-018-0116-x. Epub 2018 Nov 10.
2018
AOU San Luigi di Orbassano

Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Pia Sormani M; Ghezzi A;

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.
2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study. in Journal of neurology / J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.
2018
AOU San Luigi di Orbassano

Mallucci G; Annovazzi P; Miante S; Torri-Clerici V; Matta M; La Gioia S; Cavarretta R; Mantero V; Costantini G; D'Ambrosio V; Zaffaroni M; Ghezzi A; Perini P; Rossi S; Bertolotto A; Rottoli MR; Rovaris M; Balgera R; Cavalla P; Montomoli C; Bergamaschi R;

Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses. in Journal of neuroimmunology / J Neuroimmunol. 2017 Dec 15;313:89-91. doi: 10.1016/j.jneuroim.2017.10.009. Epub 2017 Oct 17.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Vladic A; Annovazzi P; Cocco E; Adamec I; Habek M; Horakova D; Bardina V; Rolla S; De Mercanti SF;

A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31.
2017
AOU San Luigi di Orbassano

Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Sormani MP; Ghezzi A;

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. in Journal of neurology / J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.
2016
AOU San Luigi di Orbassano

Moiola L; Annovazzi P; Capobianco M; Patti F; Frau J; Uccelli A; Centonze D; Perini P; Tortorella C; Prosperini L; Lus G; Fuiani A; Falcini M; Martinelli V; Comi G; Ghezzi A;

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 21;3(1):e194. doi: 10.1212/NXI.0000000000000194. eCollect
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Annovazzi P; Horakova D; Adamec I; Habek M; Soldo-Butkovic S; Vladic A; Cocco E; Bardina V; Cucci A; Rolla S; De Mercanti S;

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2014 Aug;20(9):1265-8. doi: 10.1177/1352458514521311. Epub 2014 Feb 10.
2014
AOU San Luigi di Orbassano

Frisullo G; Calabrese M; Tortorella C; Paolicelli D; Ragonese P; Annovazzi P; Radaelli M; Malucchi S; Gallo A; Tomassini V; Nociti V; D'Onghia M; Lo Re V; Rodegher M; Solaro C; Gasperini C;